Items where Author is "Wong, Charng Choon"
Up a level |
Group by: Item Type | No Grouping
Number of items: 6.
Wong, Charng Choon and Lim, Siang Hui and Sagineedu, Sreenivasa Rao and Lajis, Nordin and Stanslas, Johnson
(2016)
SRJ09, a promising anticancer drug lead: elucidation of mechanisms of antiproliferative and apoptogenic effects and assessment of in vivo antitumor efficacy.
Pharmacological Research, 107 (1).
pp. 66-78.
ISSN 1043-6618; ESSN: 1096-1186
Wong, Charng Choon
(2016)
Elucidation of anticancer activity mechanism of 3,19-(2-Bromobenzylidene) andrographolide (SRJ09) in breast and colon cancer cells.
Doctoral thesis, Universiti Putra Malaysia.
Wong, Charng Choon and Periasamy, Nagarajan and Sagineedu, Sreenivasa Rao and Mohd Sidik, Shiran and Sumon, Md. Shariful Hasan and Loadman, Paul and Phillips, Roger and Lajis, Md. Nordin and Stanslas, Johnson
(2014)
In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog.
Investigational New Drugs, 32 (5).
pp. 806-814.
ISSN 0167-6997; ESSN: 1573-0646
Wong, Hui Chyn and Wong, Charng Choon and Sagineedu, Sreenivasa Rao and Loke, Seng Cheong and Lajis, Nordin and Stanslas, Johnson
(2014)
SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Cell Biology and Toxicology, 30 (5).
pp. 269-288.
ISSN 0742-2091; ESSN: 1573-6822
Wong, Charng Choon and Sagineedu, Sreenivasa Rao and Sumon, Shariful Hasan and Mohamad Sidik, Shiran and Phillips, Roger and Lajis, Nordin and Stanslas, Johnson
(2014)
NCI in vitro and in silico anticancer screen, cell cycle pertubation and apoptosis-inducing potential of new acylated, benzylidene and isopropylidene derivatives of andrographolide.
Environmental Toxicology and Pharmacology, 38 (2).
pp. 489-501.
ISSN 1382-6689; ESSN: 1872-7077
Stanslas, Johnson and Lim, Siang Hui and Wong, Charng Choon and Sagineedu, Sreenivasa Rao and Lajis, Nordin
(2010)
Andrographolide as a template in the synthesis of new anticancer agents with potentially novel molecular targets.
The FASEB Journal, 24.
ISSN 0892-6638; ESSN: 1530-6860